Immune Checkpoint Inhibitors with Dr. Kerry Reynolds
Curbside Consults
00:00
Understanding Tumor Proportion Score and Immune Checkpoint Inhibitors
This chapter explores the significance of TPS as a biomarker for predicting the response to immune checkpoint inhibitors, explaining its measurement and variability across different cancer types. The speakers also touch upon the importance of monitoring for multi-system toxicity and immune-related adverse events.
Transcript
Play full episode
